4-37960628-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006607.3(PTTG2):c.194G>A(p.Gly65Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000432 in 1,614,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006607.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PTTG2 | NM_006607.3 | c.194G>A | p.Gly65Asp | missense_variant | 1/1 | ENST00000504686.2 | |
TBC1D1 | NM_001396959.1 | c.418-53881G>A | intron_variant | ENST00000698857.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PTTG2 | ENST00000504686.2 | c.194G>A | p.Gly65Asp | missense_variant | 1/1 | NM_006607.3 | P1 | ||
TBC1D1 | ENST00000698857.1 | c.418-53881G>A | intron_variant | NM_001396959.1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000339 AC: 85AN: 250792Hom.: 0 AF XY: 0.000294 AC XY: 40AN XY: 135828
GnomAD4 exome AF: 0.000438 AC: 640AN: 1461894Hom.: 0 Cov.: 33 AF XY: 0.000439 AC XY: 319AN XY: 727248
GnomAD4 genome AF: 0.000381 AC: 58AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.000295 AC XY: 22AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2022 | The c.194G>A (p.G65D) alteration is located in exon 1 (coding exon 1) of the PTTG2 gene. This alteration results from a G to A substitution at nucleotide position 194, causing the glycine (G) at amino acid position 65 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at